FSSNX
Price
$27.77
Change
-$0.31 (-1.10%)
Updated
Sep 20 closing price
RSCRX
Price
$28.90
Change
-$0.31 (-1.06%)
Updated
Sep 20 closing price
Ad is loading...

FSSNX vs RSCRX

Header iconFSSNX vs RSCRX Comparison
Open Charts FSSNX vs RSCRXBanner chart's image
Fidelity Small Cap Index
Price$27.77
Change-$0.31 (-1.10%)
VolumeN/A
CapitalizationN/A
Russell Inv US Small Cap Equity R6
Price$28.90
Change-$0.31 (-1.06%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FSSNX vs RSCRX Comparison Chart
Loading...
VS
FSSNX vs. RSCRX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSNX is a StrongBuy and RSCRX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 27.3B vs. RSCRX (894M). FSSNX pays higher dividends than RSCRX: FSSNX (1.36) vs RSCRX (0.61). FSSNX was incepted earlier than RSCRX: FSSNX (13 years) vs RSCRX (9 years). RSCRX is a more actively managed with annual turnover of: 80.00 vs. FSSNX (9.00). FSSNX (0) and RSCRX (0) have matching initial minimum investment requirements. FSSNX annual gain was more profitable for investors over the last year : 22.65 vs. RSCRX (16.71). FSSNX return over 5 years is better than : 44.62 vs. RSCRX (4.12).
FSSNXRSCRXFSSNX / RSCRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years9 years-
Gain YTD9.9728.169122%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets27.3B894M3,054%
Annual Yield % from dividends1.360.61223%
Returns for 1 year22.6516.71136%
Returns for 3 years0.65-23.49-3%
Returns for 5 years44.624.121,083%
Returns for 10 years84.24N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLMD3.490.05
+1.45%
Relmada Therapeutics
BSAC20.240.18
+0.90%
Banco Santander-Chile
ODC67.85-0.79
-1.15%
Oil-Dri Corp
HRMY38.34-0.47
-1.21%
Harmony Biosciences Holdings
THAR2.94-0.05
-1.67%
Tharimmune Inc.